Detailed information for compound 1821212

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 1145.55 | Formula: C71H100O12
  • H donors: 2 H acceptors: 3 LogP: 15.5 Rotable bonds: 40
    Rule of 5 violations (Lipinski): 2
  • SMILES: CCCCCC[C@@H](CCC[C@@H]([C@H]1CC[C@@H](O1)[C@H]1CC[C@@H](O1)[C@H](OC[C@H]1O[C@H](OCc2ccccc2)[C@@H]([C@H]([C@@H]1OCc1ccccc1)OCc1ccccc1)OCc1ccccc1)CCCCCCCCCCCCC1=C[C@@H](OC1=O)C)O)O
  • InChi: 1S/C71H100O12/c1-3-4-5-27-39-59(72)40-29-41-60(73)61-43-44-64(81-61)65-46-45-63(82-65)62(42-28-13-11-9-7-6-8-10-12-26-38-58-47-53(2)80-70(58)74)75-52-66-67(76-48-54-30-18-14-19-31-54)68(77-49-55-32-20-15-21-33-55)69(78-50-56-34-22-16-23-35-56)71(83-66)79-51-57-36-24-17-25-37-57/h14-25,30-37,47,53,59-69,71-73H,3-13,26-29,38-46,48-52H2,1-2H3/t53-,59-,60-,61+,62+,63+,64+,65+,66+,67+,68-,69+,71-/m0/s1
  • InChiKey: ZLVTXOPNEYOZHF-SBMRFALFSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Brugia malayi Latrophilin receptor protein 2 0.0016 0.0085 0.0085
Trypanosoma cruzi mitogen activated protein kinase 2, putative 0.0508 1 1
Loa Loa (eye worm) thioredoxin reductase 0.0073 0.1244 0.1244
Brugia malayi Thioredoxin reductase 0.0073 0.1244 0.1244
Loa Loa (eye worm) TK/KIN16 protein kinase 0.0013 0.0021 0.0021
Brugia malayi Pyridine nucleotide-disulphide oxidoreductase, dimerisation domain containing protein 0.0019 0.0142 0.0142
Trypanosoma brucei trypanothione reductase 0.0073 0.1244 0.0994
Loa Loa (eye worm) latrophilin receptor protein 2 0.0016 0.0085 0.0085
Brugia malayi latrophilin 2 splice variant baaae 0.0034 0.0455 0.0455
Leishmania major trypanothione reductase 0.0073 0.1244 0.0994
Plasmodium vivax thioredoxin reductase, putative 0.0073 0.1244 1
Echinococcus multilocularis dihydrolipoamide dehydrogenase 0.0025 0.0278 0.0278
Trypanosoma cruzi mitogen-activated protein kinase 11, putative 0.0508 1 1
Wolbachia endosymbiont of Brugia malayi dihydrolipoamide dehydrogenase E3 component 0.0025 0.0278 0.5
Loa Loa (eye worm) hypothetical protein 0.0015 0.006 0.006
Echinococcus granulosus mitogen activated protein kinase 3 0.0508 1 1
Loa Loa (eye worm) pigment dispersing factor receptor c 0.005 0.0774 0.0774
Echinococcus multilocularis GPCR, family 2 0.0016 0.0085 0.0085
Echinococcus multilocularis basic fibroblast growth factor receptor 1 A 0.01 0.1776 0.1776
Loa Loa (eye worm) hypothetical protein 0.005 0.0774 0.0774
Schistosoma mansoni hypothetical protein 0.0016 0.0085 0.0085
Echinococcus multilocularis diuretic hormone 44 receptor GPRdih2 0.0016 0.0085 0.0085
Echinococcus granulosus GPCR family 2 0.0016 0.0085 0.0085
Schistosoma mansoni nephrin 0.0015 0.006 0.006
Mycobacterium tuberculosis NADPH-dependent mycothiol reductase Mtr 0.0073 0.1244 1
Trichomonas vaginalis CMGC family protein kinase 0.0508 1 1
Brugia malayi Calcitonin receptor-like protein seb-1 0.005 0.0774 0.0774
Giardia lamblia Kinase, CMGC MAPK 0.0508 1 1
Treponema pallidum NADH oxidase 0.0025 0.0278 0.5
Toxoplasma gondii thioredoxin reductase 0.0073 0.1244 0.0994
Toxoplasma gondii CMGC kinase, MAPK family (ERK) MAPK-1 0.0508 1 1
Echinococcus granulosus dihydrolipoamide dehydrogenase 0.0025 0.0278 0.0278
Echinococcus granulosus cadherin EGF LAG seven pass G type receptor 0.0016 0.0085 0.0085
Echinococcus granulosus twitchin 0.0019 0.0153 0.0153
Echinococcus multilocularis fibroblast growth factor receptor 4 0.01 0.1776 0.1776
Echinococcus granulosus basic fibroblast growth factor receptor 1 A 0.01 0.1776 0.1776
Loa Loa (eye worm) hypothetical protein 0.0015 0.006 0.006
Leishmania major mitogen activated protein kinase, putative,map kinase, putative 0.0508 1 1
Loa Loa (eye worm) glutathione reductase 0.0073 0.1244 0.1244
Trichomonas vaginalis CMGC family protein kinase 0.0508 1 1
Trypanosoma cruzi trypanothione reductase, putative 0.0073 0.1244 0.0994
Echinococcus granulosus mitogen activated protein kinase 0.0508 1 1
Echinococcus granulosus thioredoxin glutathione reductase 0.0073 0.1244 0.1244
Brugia malayi Corticotropin releasing factor receptor 2 precursor, putative 0.005 0.0774 0.0774
Brugia malayi glutathione reductase 0.0073 0.1244 0.1244
Brugia malayi alpha keto acid dehydrogenase complex, E3 component, lipoamide dehydrogenase 0.0019 0.0142 0.0142
Echinococcus multilocularis neuroglian 0.0015 0.006 0.006
Echinococcus granulosus roundabout 2 0.0015 0.006 0.006
Mycobacterium ulcerans dihydrolipoamide dehydrogenase, LpdB 0.0025 0.0278 0.5
Chlamydia trachomatis dihydrolipoyl dehydrogenase 0.0025 0.0278 0.5
Trypanosoma brucei protein kinase, putative 0.0508 1 1
Trypanosoma cruzi mitogen activated protein kinase 4, putative 0.0508 1 1
Plasmodium falciparum glutathione reductase 0.0073 0.1244 1
Loa Loa (eye worm) TK protein kinase 0.0103 0.1836 0.1836
Echinococcus granulosus neuroglian 0.0015 0.006 0.006
Schistosoma mansoni hypothetical protein 0.0016 0.0085 0.0085
Brugia malayi calcium-independent alpha-latrotoxin receptor 2, putative 0.0016 0.0085 0.0085
Echinococcus multilocularis mitogen activated protein kinase 0.0508 1 1
Trichomonas vaginalis CMGC family protein kinase 0.0508 1 1
Echinococcus multilocularis cadherin EGF LAG seven pass G type receptor 0.0016 0.0085 0.0085
Schistosoma mansoni hypothetical protein 0.0016 0.0085 0.0085
Mycobacterium ulcerans dihydrolipoamide dehydrogenase 0.0025 0.0278 0.5
Plasmodium vivax glutathione reductase, putative 0.0073 0.1244 1
Schistosoma mansoni dihydrolipoamide dehydrogenase 0.0025 0.0278 0.0278
Echinococcus multilocularis thioredoxin glutathione reductase 0.0073 0.1244 0.1244
Schistosoma mansoni serine/threonine protein kinase 0.0508 1 1
Brugia malayi Immunoglobulin I-set domain containing protein 0.0103 0.1836 0.1836
Trichomonas vaginalis CMGC family protein kinase 0.0508 1 1
Echinococcus granulosus diuretic hormone 44 receptor GPRdih2 0.0016 0.0085 0.0085
Schistosoma mansoni tyrosine kinase 0.01 0.1776 0.1776
Mycobacterium leprae DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE 0.0025 0.0278 0.5
Echinococcus granulosus fibroblast growth factor receptor 4 0.01 0.1776 0.1776
Brugia malayi dihydrolipoyl dehydrogenase, mitochondrial precursor, putative 0.0025 0.0278 0.0278
Wolbachia endosymbiont of Brugia malayi dihydrolipoamide dehydrogenase E3 component 0.0025 0.0278 0.5
Schistosoma mansoni hypothetical protein 0.0016 0.0085 0.0085
Schistosoma mansoni hypothetical protein 0.0034 0.0455 0.0455
Brugia malayi Immunoglobulin I-set domain containing protein 0.0013 0.0021 0.0021
Echinococcus multilocularis mitogen activated protein kinase 3 0.0508 1 1
Trypanosoma cruzi mitogen-activated protein kinase 11, putative 0.0508 1 1
Mycobacterium ulcerans flavoprotein disulfide reductase 0.0025 0.0278 0.5
Loa Loa (eye worm) CMGC/MAPK/ERK1 protein kinase 0.0508 1 1
Trypanosoma brucei mitogen activated protein kinase 4, putative 0.0508 1 1
Loa Loa (eye worm) hypothetical protein 0.0034 0.0455 0.0455
Loa Loa (eye worm) hypothetical protein 0.0016 0.0085 0.0085
Plasmodium falciparum thioredoxin reductase 0.0073 0.1244 1
Echinococcus multilocularis roundabout 2 0.0015 0.006 0.006
Leishmania major mitogen activated protein kinase 4, putative;with=GeneDB:LmxM19.1440 0.0508 1 1

Activities

Activity type Activity value Assay description Source Reference
Inhibition (functional) = 65 % Cell Cycle inhibition against mouse lymphocytic leukemia cells (L1210) at 10 microM ChEMBL. 10780917

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.